Add to Favourites
To login click here
Exscientia plc held a business update call for the full year ended 2022, during which their Vice President of Investor Relations, Sara Sherman, discussed their financial results and business progress. The call was attended by the company’s Founder, CEO & Executive Director, Andrew L. Hopkins, CFO, Chief Strategy Officer & Executive Director, Ben R. Taylor, Chief Scientific Officer, David Hallett, CTO, Garry Pairaudeau, Chief Quantitative Medicine Officer, Michael Krams, and VP of IR, Sara Sherman, as well as a research analyst from Barclays Bank PLC, Research Division, an unidentified analyst, and an equity analyst from Morgan Stanley, Research Division.